Mather Group
TEVA icon

Mather Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mather Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.3K Buy
362
+217
+150% +$7.76K ﹤0.01% 1532
2026
Q2 		$4.92K Buy
145
+135
+1,350% +$4.5K ﹤0.01% 1625
2026
Q1 		$305 Buy
+10
New +$322 ﹤0.01% 1829
2024
Q3 		– Sell
-339
Closed -$4.78K – 2165
2024
Q2 		$4.78K Buy
+339
New +$5.22K ﹤0.01% 1633

Other funds holding TEVA

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Evelyn Partners
Evelyn Partners London $6.26B AUM

Mather Group's TEVA Position: Q3 2026 in Review

Mather Group increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 150% in Q3 2026, buying an estimated $7.76K and bringing the position to 362 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Mather Group first reported a position in TEVA in Q2 2024 and has held it in 4 quarters since. 308 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Mather Group held 362 shares of Teva Pharmaceutical Industries Limited worth $14.3K as of Q3 2026.
  • Mather Group bought 217 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $7.76K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1532 holding.
  • Mather Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 4 quarters since.
  • 308 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.